Sumitomo Mitsui Trust Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $851M | Sell |
3,914,633
-188,212
| -5% | -$41.7M | 0.55% | 27 |
|
|
2025
Q4 | $937M | Sell |
4,102,845
-153,226
| -4% | -$34.9M | 0.55% | 24 |
|
|
2025
Q3 | $985M | Buy |
4,256,071
+66,358
| +2% | +$13.5M | 0.57% | 25 |
|
|
2025
Q2 | $778M | Buy |
4,189,713
+86,113
| +2% | +$16M | 0.48% | 32 |
|
|
2025
Q1 | $860M | Sell |
4,103,600
-9,961
| -0.2% | -$1.94M | 0.61% | 26 |
|
|
2024
Q4 | $731M | Sell |
4,113,561
-5,674
| -0.1% | -$1.04M | 0.49% | 29 |
|
|
2024
Q3 | $813M | Buy |
4,119,235
+38,854
| +1% | +$7.25M | 0.56% | 26 |
|
|
2024
Q2 | $700M | Sell |
4,080,381
-287,000
| -7% | -$47.5M | 0.52% | 28 |
|
|
2024
Q1 | $795M | Sell |
4,367,381
-61,058
| -1% | -$10.5M | 0.55% | 28 |
|
|
2023
Q4 | $686M | Sell |
4,428,439
-15,453
| -0.3% | -$2.25M | 0.51% | 32 |
|
|
2023
Q3 | $662M | Sell |
4,443,892
-47,992
| -1% | -$7.05M | 0.54% | 27 |
|
|
2023
Q2 | $605M | Sell |
4,491,884
-662,544
| -13% | -$97.2M | 0.47% | 38 |
|
|
2023
Q1 | $821M | Sell |
5,154,428
-91,711
| -2% | -$14M | 0.61% | 23 |
|
|
2022
Q4 | $848M | Sell |
5,246,139
-1,694
| -0% | -$260K | 0.67% | 23 |
|
|
2022
Q3 | $704M | Sell |
5,247,833
-36,478
| -0.7% | -$5.23M | 0.58% | 26 |
|
|
2022
Q2 | $809M | Sell |
5,284,311
-425,086
| -7% | -$65M | 0.62% | 22 |
|
|
2022
Q1 | $926M | Sell |
5,709,397
-492,851
| -8% | -$71.6M | 0.62% | 19 |
|
|
2021
Q4 | $840M | Sell |
6,202,248
-952,367
| -13% | -$112M | 0.51% | 31 |
|
|
2021
Q3 | $772M | Buy |
7,154,615
+19,933
| +0.3% | +$2.28M | 0.48% | 38 |
|
|
2021
Q2 | $804M | Sell |
7,134,682
-531,511
| -7% | -$59.9M | 0.48% | 36 |
|
|
2021
Q1 | $830M | Sell |
7,666,193
-57,246
| -0.7% | -$6.12M | 0.52% | 31 |
|
|
2020
Q4 | $828M | Sell |
7,723,439
-649,937
| -8% | -$62.5M | 0.53% | 28 |
|
|
2020
Q3 | $733M | Buy |
8,373,376
+179,105
| +2% | +$16.9M | 0.49% | 39 |
|
|
2020
Q2 | $795M | Buy |
8,194,271
+1,630,022
| +25% | +$144M | 0.56% | 32 |
|
|
2020
Q1 | $493M | Buy |
6,564,249
+666,883
| +11% | +$56.8M | 0.42% | 48 |
|
|
2019
Q4 | $515M | Buy |
5,897,366
+79,374
| +1% | +$6.59M | 0.41% | 46 |
|
|
2019
Q3 | $441M | Buy |
5,817,992
+48,571
| +0.8% | +$3.33M | 0.38% | 54 |
|
|
2019
Q2 | $420M | Sell |
5,769,421
-190,021
| -3% | -$14.9M | 0.37% | 54 |
|
|
2019
Q1 | $480M | Buy |
5,959,442
+170,031
| +3% | +$13.9M | 0.44% | 47 |
|
|
2018
Q4 | $528M | Buy |
5,789,411
+963,633
| +20% | +$84.7M | 0.57% | 34 |
|
|
2018
Q3 | $456M | Buy |
4,825,778
+79,330
| +2% | +$7.52M | 0.49% | 41 |
|
|
2018
Q2 | $440M | Sell |
4,746,448
-208,061
| -4% | -$20.3M | 0.51% | 39 |
|
|
2018
Q1 | $469M | Buy |
4,954,509
+281,453
| +6% | +$30.9M | 0.6% | 34 |
|
|
2017
Q4 | $452M | Buy |
4,673,056
+167,382
| +4% | +$15.8M | 0.58% | 37 |
|
|
2017
Q3 | $400M | Sell |
4,505,674
-64,892
| -1% | -$4.94M | 0.57% | 37 |
|
|
2017
Q2 | $331M | Buy |
4,570,566
+46,487
| +1% | +$3.13M | 0.49% | 41 |
|
|
2017
Q1 | $295M | Buy |
4,524,079
+6,084
| +0.1% | +$383K | 0.46% | 43 |
|
|
2016
Q4 | $283M | Sell |
4,517,995
-183,442
| -4% | -$11.2M | 0.46% | 41 |
|
|
2016
Q3 | $297M | Buy |
4,701,437
+182,686
| +4% | +$11.8M | 0.49% | 41 |
|
|
2016
Q2 | $280M | Sell |
4,518,751
-150,997
| -3% | -$9.2M | 0.48% | 42 |
|
|
2016
Q1 | $267M | Buy |
4,669,748
+81,339
| +2% | +$4.53M | 0.47% | 43 |
|
|
2015
Q4 | $274M | Sell |
4,588,409
-144,961
| -3% | -$8.35M | 0.49% | 41 |
|
|
2015
Q3 | $258M | Buy |
4,733,370
+157,387
| +3% | +$10.2M | 0.5% | 39 |
|
|
2015
Q2 | $305M | Buy |
4,575,983
+300,639
| +7% | +$19.6M | 0.55% | 38 |
|
|
2015
Q1 | $250M | Buy |
4,275,344
+446,064
| +12% | +$26.9M | 0.45% | 47 |
|
|
2014
Q4 | $252M | Sell |
3,829,280
-92,470
| -2% | -$5.83M | 0.49% | 40 |
|
|
2014
Q3 | $227M | Buy |
3,921,750
+89,924
| +2% | +$4.99M | 0.45% | 43 |
|
|
2014
Q2 | $216M | Sell |
3,831,826
-271,120
| -7% | -$14.2M | 0.44% | 46 |
|
|
2014
Q1 | $211M | Buy |
4,102,946
+41,113
| +1% | +$2.08M | 0.44% | 47 |
|
|
2013
Q4 | $215M | Sell |
4,061,833
-176,910
| -4% | -$8.69M | 0.45% | 46 |
|
|
2013
Q3 | $188M | Sell |
4,238,743
-38,814
| -0.9% | -$1.72M | 0.41% | 54 |
|
|
2013
Q2 | $175M | Buy |
+4,277,557
| New | +$187M | 0.4% | 54 |
|
Other funds holding ABBV
VCM
VPM
Sumitomo Mitsui Trust Group's ABBV Position: Q1 2026 in Review
Sumitomo Mitsui Trust Group reduced its AbbVie (ABBV) stake by 4.6% in Q1 2026, selling an estimated $41.7M and leaving 3,914,633 shares worth $851M. The position accounts for 0.55% of the portfolio, ranked #27.
Sumitomo Mitsui Trust Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $985M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Sumitomo Mitsui Trust Group held 3,914,633 shares of AbbVie worth $851M as of Q1 2026.
- Sumitomo Mitsui Trust Group sold 188,212 AbbVie shares in Q1 2026, an estimated $41.7M.
- AbbVie made up 0.55% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #27 holding.
- Sumitomo Mitsui Trust Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Sumitomo Mitsui Trust Group's AbbVie position peaked at $985M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.